Skip to main content

FluSure XP/FarrowSure GOLD B (Canada)

This page contains information on FluSure XP/FarrowSure GOLD B for veterinary use.
The information provided typically includes the following:
  • FluSure XP/FarrowSure GOLD B Indications
  • Warnings and cautions for FluSure XP/FarrowSure GOLD B
  • Direction and dosage information for FluSure XP/FarrowSure GOLD B

FluSure XP/FarrowSure GOLD B

This treatment applies to the following species:
Company: Zoetis

Parvovirus-Swine Influenza Vaccine, H1N1 & H3N2

Killed Virus

Erysipelothrix Rhusiopathiae-Leptospira Bratislava-Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For use in swine only

For veterinary use only

For vaccination of healthy breeding swine, including pregnant sows and gilts, as an aid in preventing respiratory disease caused by SIV subtypes H1N1 and H3N2, reproductive failure caused by PPV, and disease caused by Erysipelothrix rhusiopathiae, Leptospira bratislava, L. canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona. An 18-week duration of immunity following vaccination has been demonstrated against erysipelas. This product contains the following SIV isolates: A/Swine/North Carolina/031/05 (H1N1); A/Swine/Missouri/069/05 (H3N2); and A/Swine/Iowa/110600/00 (H1N1).

Directions For Use

Aseptically rehydrate the freeze-dried vaccine with the liquid component provided, shake well, and administer 2 mL intramuscularly. Healthy swine should receive 2 doses 3-5 weeks apart with the second dose administered 2-4 weeks prior to breeding. Healthy gilts, however, should receive the second dose as near as possible to 14 days prior to breeding. Revaccination with a single dose is recommended prior to subsequent breedings. Boars should be revaccinated semiannually.


Store at 2°-7°C. Do not freeze. Use entire contents when first opened or rehydrated. Sterilized syringes and needles should be used to administer this vaccine. Do not vaccinate within 21 days before slaughter. Contains gentamicin as preservative. Temporary swelling at the injection site may be observed. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).

™ Trademark of Zoetis Inc., its subsidiaries or licensors; Zoetis Canada as licensee.

® Registered trademark of Zoetis Inc., its subsidiaries or licensors; Zoetis Canada as licensee.

U.S. Veterinary License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

50-dose vial of vaccine, rehydrate to 100 mL

100-mL vial of liquid component for use as diluent



CPN: 1198442.2

Order Desk:   800-663-8888
Technical Services Canada:   800-461-0917
Technical Services USA:   800-366-5288
This service and data are provided "AS IS". DVMetrics and assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics and services and data. See the terms of use for further details.

Copyright © 2022 Animalytix LLC. Updated: 2021-11-29